334 related articles for article (PubMed ID: 22409994)
21. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif.
Ye S; MacEachran DP; Hamilton JW; O'Toole GA; Stanton BA
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C807-18. PubMed ID: 18650266
[TBL] [Abstract][Full Text] [Related]
22. Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo.
Zhao XQ; Xie JD; Chen XG; Sim HM; Zhang X; Liang YJ; Singh S; Talele TT; Sun Y; Ambudkar SV; Chen ZS; Fu LW
Mol Pharmacol; 2012 Jul; 82(1):47-58. PubMed ID: 22491935
[TBL] [Abstract][Full Text] [Related]
23. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW
Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561
[TBL] [Abstract][Full Text] [Related]
24. Generating inhibitors of P-glycoprotein: where to, now?
Crowley E; McDevitt CA; Callaghan R
Methods Mol Biol; 2010; 596():405-32. PubMed ID: 19949934
[TBL] [Abstract][Full Text] [Related]
25. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
[TBL] [Abstract][Full Text] [Related]
26. Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.
Hu XF; Slater A; Kantharidis P; Rischin D; Juneja S; Rossi R; Lee G; Parkin JD; Zalcberg JR
Blood; 1999 Jun; 93(12):4086-95. PubMed ID: 10361105
[TBL] [Abstract][Full Text] [Related]
27. PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism.
Walter RB; Pirga JL; Cronk MR; Mayer S; Appelbaum FR; Banker DE
Blood; 2005 Nov; 106(10):3584-93. PubMed ID: 16051742
[TBL] [Abstract][Full Text] [Related]
28. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
Ho MM; Hogge DE; Ling V
Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
[TBL] [Abstract][Full Text] [Related]
29. Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation.
Tan SF; Dunton W; Liu X; Fox TE; Morad SAF; Desai D; Doi K; Conaway MR; Amin S; Claxton DF; Wang HG; Kester M; Cabot MC; Feith DJ; Loughran TP
J Lipid Res; 2019 Jun; 60(6):1078-1086. PubMed ID: 30962310
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
31. The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter.
Ding PR; Tiwari AK; Ohnuma S; Lee JW; An X; Dai CL; Lu QS; Singh S; Yang DH; Talele TT; Ambudkar SV; Chen ZS
PLoS One; 2011 Apr; 6(4):e19329. PubMed ID: 21552528
[TBL] [Abstract][Full Text] [Related]
32. A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.
Kelly RJ; Robey RW; Chen CC; Draper D; Luchenko V; Barnett D; Oldham RK; Caluag Z; Frye AR; Steinberg SM; Fojo T; Bates SE
Oncologist; 2012; 17(4):512. PubMed ID: 22416063
[TBL] [Abstract][Full Text] [Related]
33. A novel human multidrug resistance gene MDR1 variant G571A (G191R) modulates cancer drug resistance and efflux transport.
Yang Z; Wu D; Bui T; Ho RJ
J Pharmacol Exp Ther; 2008 Nov; 327(2):474-81. PubMed ID: 18723777
[TBL] [Abstract][Full Text] [Related]
34. Novel mechanisms of drug resistance in leukemia.
Ross DD
Leukemia; 2000 Mar; 14(3):467-73. PubMed ID: 10720143
[TBL] [Abstract][Full Text] [Related]
35. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of ABCB1 genotyping in oncology.
Hamidovic A; Hahn K; Kolesar J
J Oncol Pharm Pract; 2010 Mar; 16(1):39-44. PubMed ID: 19401306
[TBL] [Abstract][Full Text] [Related]
37. Membrane transport and apoptosis-related proteins in radiation-associated acute myeloid leukemia following the Chornobyl accident.
Klymenko SV; Ilyenko IN; Golarnik NA; Maznichenko OL; Breier A; Bazyka DA
Gen Physiol Biophys; 2009 Mar; 28(1):63-9. PubMed ID: 19390138
[TBL] [Abstract][Full Text] [Related]
38. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
39. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF
Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
[TBL] [Abstract][Full Text] [Related]
40. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
Leith CP; Kopecky KJ; Godwin J; McConnell T; Slovak ML; Chen IM; Head DR; Appelbaum FR; Willman CL
Blood; 1997 May; 89(9):3323-9. PubMed ID: 9129038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]